type full_text Care Plan TCU HAE ambu clinic Dr [REDACTED] [REDACTED] [REDACTED][REDACTED] on 17/01/24 with FBC, crea GXM OA HAE to repeat CXR in 6 8/52 (as per respiratory medicine), TCU Dr [REDACTED] [REDACTED] [REDACTED] [REDACTED] [REDACTED] [REDACTED][REDACTED] 95/Chi/MNKDAStays with helper and 80 [REDACTED] wife PMH 1. Prev cholecystectomy 2. HTN 3. Rt. RCC > Right superior renal tumour cryoablation Lipiodol and coil embolisation 10/09/20 p/w symptomatic large pericardial effusion s/p emergency pericardial tap 05/12/19 , 500 ml blood stained (lymphocytic yeild) Fe def anemia / CT TAP 08/12/19: Large Rt. RCC bilateral pleural effusions and pericardial effusion Focal nodular enhancement of the pericardium is identified but is nonspecific. Pleural fluid 16/12/19 reactive lymphoid yield, ve for malignant cells 4. Fe defiency anemia 5. pAF / CHADVAS 3 / DSE 27/12/19 ve for ischemia > started rivaroxaban Haematology 1. Hypoproliferative marrow Anemia of chronic illness transfusion dependent p/w pancytopenia no evidence of bone mets, MDS, Acute Leuk/Lymphoma EPO level 547 (nv 2.6 18.5) EPO level (post embolization) 09/02/21 1697 IU/L (2.6 18.50) not responsive to recormon, danazol Cx iron overloading not for chelation ivo age, comorbids, side effects offered Cipro prophylaxis 05/2023 patient refused NOT YET fungal prophylaxis (need to watch LFTs) > for best supportive care > Transfusion dependent requiring 1 U BPC every 2 weeks Blood group : O Positive needs PCT(F) blood no antibodiesBMAT 24/11/20 Aspirate BONE MARROW ASPIRATE SHOWS HYPERCELLULAR PARTICLES WITH HYPOCELLULAR DILUTED TRAILS. GROSS ERYTHROID HYPOPLASIA WITH RELATIVELY NORMAL MYELOPOIESIS AND MEGAKARYOPOIESIS, WITHOUT OBVIOUS DYSPLASTIC FEATURES OR ABNORMAL INFILTRATION. Flow: Flow cytometry analysis of bone marrow sample demonstrates 0.2 myeloid progenitors with no aberrant expression. No evidence of significant dysplasia is present based on immunophenotypic patterns. There is also no evidence of clonal lymphoid populations.Bone marrow trephine: Normocellular marrow with mildly reduced erythropoiesis.Comment: There is no evidence of metastatic carcinoma in this biopsy.Cellularity 10 normal for ageFibrosis 1 /4 FISH negative for MDSKaryotype Normal 46 XY Current Admission Walked in to ambu clinic Recently admitted 13 18/12/23 for COVID pneumonia complicated by fast AFStill persistently breathless since dischargeGiven 1 BPC in ambu clinicOn review in ward,Has been having SOB and cough since dischargeHowever SOB worse these 2 daysUnable to walk (baseline able to walk with walking stick with hand holding by helper)White to yellow sputum with coughNo hemoptysisNo rhinorrhea/sore throatNo abdominal pain but constipated despite laxativesNo dysuria/hematuriaAppetite poor since dischargeNo new sick contact but wife was sick with COVID before patient was affectedCompleted blood transfusion ~2:30 pm in Haem Centre Objective VitalsT afebrileHR 57 BP 185/67 SPo 2 95 RAO/EAlert, comfortableSpeaking in full sentences, non toxicHeart S 1 S 2 Lungs Decreased air entry right baseAbdo Soft, non tenderCalves supple, no LL edema Issues and Progress 1. Right LZ hospital acquired pneumonia with possible parapneumonic effusionb/g recent COVID pneumonia procal 0.20 CRP 13.9 CXR: There is consolidation in the right lower zone, suggestive of infection. Small right pleural effusion is noted. Blood cultures NBG MERS CoV respiratory panel: COVID positive Covered with IV Tazocin, oralised to augmentin to complete 2 weeks Had fluid responsive hypotension 03/01/24 with BP 88/57 to 108/54 after 1 pint Hartmann's solution Noted choking on food thus reviewed by ST diet consistency advised seen by respi for thoracocentesis of R pleural effusion, held off in view of soft indication and low plt counts 2. b/g Hypoproliferative marrow Anemia of chronic illness transfusion dependent, on best supportive careMed changesComplete augmentin 7 daysPatient was discharged well on 12/1/2024 Patient and family keen for dischargeCGT was completed to helper, home with AIC for home therapy